Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 81 Leukemia 41 Gastrointestinal Stromal Tumors 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Leukemia, Myeloid, Chronic-Phase 27 Blast Crisis 13 Neoplasms 10 Neoplasm Metastasis 10 Melanoma 10 Brain Neoplasms 10 Lung Neoplasms 9 Prostatic Neoplasms 8 Leukemia, Myeloid, Acute 8 Gliosarcoma 8 Glioblastoma 8 Leukemia, Myeloid, Accelerated Phase 7 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Sarcoma 5 Philadelphia Chromosome 5 Oligodendroglioma 5 Recurrence 4 Primary Myelofibrosis 4 Polycythemia Vera 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Head and Neck Neoplasms 4 Central Nervous System Neoplasms 4 Breast Neoplasms 4 Astrocytoma 4

Interventions

Oxaliplatin 18 Surveys and Questionnaires 15 Fluorouracil 15 Capecitabine 13 Leucovorin 12 Blood Specimen Collection 11 Irinotecan 10 Standard of Care 7 Cisplatin 7 Endoscopic Mucosal Resection 6 atezolizumab 5 Specimen Handling 5 Radiotherapy 5 Educational Status 5 Drug Therapy 5 Docetaxel 5 S 1 (combination) 4 Radiosurgery 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Interviews as Topic 4 Gemcitabine 4 Everolimus 4 Colonoscopy 4 Biopsy 4 Bevacizumab 4 tegafur-gimeracil-oteracil 3 pemigatinib 3 apatinib 3 Remote Patient Monitoring 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gastrointestinal Neoplasms × Imatinib Mesylate × Clear all

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡